Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL828018

CN(CCN)c1ccc2cc(-c3ccccc3)[nH]c(=O)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TNKS O95271 4/20 0.42
APP P05067 2/20 0.42
KDM4E B2RXH2 2/20 0.36
PARP1 P09874 2/20 0.36
MAPT P10636 1/20 0.36
PTGER3 P43115 2/20 0.36
ALDH1A1 P00352 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
NEK1 Q96PY6 1/20 0.35
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
AR P10275 1/20 0.34
CACNA1B Q00975 1/20 0.34
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL824609 0.92 TNKS (0.48) TNKSAPPKDM4EPARP1MAPT
Trifluoroacetic Acid SCHEMBL828181 0.85 FFAR1 (0.45) TNKSKDM4EALDH1A1GLAGAA
SCHEMBL824671 0.82 TNKS (0.48) TNKSAPPKDM4EPARP1MAPT
SCHEMBL824608 0.81 TNKS (0.53) TNKSAPPKDM4EPARP1MAPT
SCHEMBL5975957 0.79 TNKS (0.43) TNKSAPPKDM4EPARP1MAPT
SCHEMBL824740 0.78 FFAR1 (0.41) TNKSAPPKDM4EALDH1A1GLA
Trifluoroacetic Acid SCHEMBL828226 0.78 PARP1 (0.38) TNKSKDM4EPARP1ALDH1A1GLA
SCHEMBL824702 0.77 TNKS (0.58) TNKSKDM4EPARP1MAPT
SCHEMBL824658 0.77 TNKS (0.45) TNKSAPPKDM4EPARP1MAPT
SCHEMBL824665 0.76 TNKS (0.44) TNKSAPPKDM4EPARP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724262-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-05-02 EP disclosed
US-8143274-B2 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2012-03-27 US disclosed
US-20070185160-A1 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-08-09 US disclosed
EP-1724262-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185160-A1 1-(2H)-isoquinolone derivative NR3C2, NR1H4, NR3C1 TNKS 4871/4885APP 3713/4885KDM4E 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.